Genome Medical Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 82

Employees

  • Latest Deal Type
  • Series D

  • Investors
  • 23

Genome Medical General Information

Description

Operator of a genomic medicine delivery company intended to bridge the gap between genome technology and current medical practice. The company connects individuals and health care providers to genetic experts, providing a genetic assessment to individuals regarding the benefits of testing and creating a personalized clinical action plan, enabling patients to make informed treatment decisions at low costs and medical practitioners to accelerate disease diagnosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 611 Gateway Boulevard
  • Suite 120
  • South San Francisco, CA 94080
  • United States
+1 (877)
Primary Industry
Clinics/Outpatient Services
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 611 Gateway Boulevard
  • Suite 120
  • South San Francisco, CA 94080
  • United States
+1 (877)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genome Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series D) 10-Sep-2024 Completed Generating Revenue
7. Later Stage VC (Series C) 25-Aug-2021 Completed Generating Revenue
6. Secondary Transaction - Private Completed Generating Revenue
5. Early Stage VC (Series B) 23-Jul-2020 Completed Generating Revenue
4. Accelerator/Incubator 01-Oct-2018 Completed Generating Revenue
3. Early Stage VC (Series A1) 22-Dec-2017 Completed Generating Revenue
2. Early Stage VC (Series A) 12-Apr-2017 $10M $12M Completed Generating Revenue
1. Seed Round 01-Nov-2016 $2M $2M Completed Startup
To view Genome Medical’s complete valuation and funding history, request access »

Genome Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A1
Series A
Seed 4,251,063 $0.000100 $0.03 $0.53 $0.53 1x $0.53 3.09%
Series AA 12,926,897 $0.000100 $0.1 $1.67 $1.67 1x $1.67 9.4%
To view Genome Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genome Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a genomic medicine delivery company intended to bridge the gap between genome technology and current medical
Clinics/Outpatient Services
South San Francisco, CA
82 As of 2026

Saint Petersburg, FL
 

Bangalore, India
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genome Medical Competitors (19)

One of Genome Medical’s 19 competitors is InformedDNA, a Venture Capital-Backed company based in Saint Petersburg, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InformedDNA Venture Capital-Backed Saint Petersburg, FL
InterpretOmics Formerly VC-backed Bangalore, India
Blueprint Genetics Formerly VC-backed Espoo, Finland
My Gene Counsel Venture Capital-Backed Branford, CT
Helix (Laboratory Services (Healthcare)) Venture Capital-Backed San Mateo, CA
You’re viewing 5 of 19 competitors. Get the full list »

Genome Medical Patents

Genome Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230386620-A1 Systems and methods for detection of potential medical conditions Inactive 27-May-2022
US-D800741-S1 Display screen or portion thereof with graphical user interface Active 25-Mar-2016
US-D800742-S1 Display screen or portion thereof with graphical user interface Active 25-Mar-2016
US-D800743-S1 Display screen or portion thereof with graphical user interface Active 25-Mar-2016
US-D800750-S1 Display screen or portion thereof with graphical user interface Active 25-Mar-2016
To view Genome Medical’s complete patent history, request access »

Genome Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genome Medical Investors (23)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amgen Ventures Corporate Venture Capital Minority
Edge (Onalaska) Corporate Venture Capital Minority
GV Corporate Venture Capital Minority
iSelect Fund Venture Capital Minority
Alumni Ventures Venture Capital Minority
You’re viewing 5 of 23 investors. Get the full list »

Genome Medical Acquisitions (1)

Genome Medical’s most recent deal was a Merger/Acquisition with GeneMatters. The deal was made on 30-Aug-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GeneMatters 30-Aug-2021 Merger/Acquisition Other Healthcare Services
To view Genome Medical’s complete acquisitions history, request access »

Genome Medical FAQs

  • When was Genome Medical founded?

    Genome Medical was founded in 2016.

  • Where is Genome Medical headquartered?

    Genome Medical is headquartered in South San Francisco, CA.

  • What is the size of Genome Medical?

    Genome Medical has 82 total employees.

  • What industry is Genome Medical in?

    Genome Medical’s primary industry is Clinics/Outpatient Services.

  • Is Genome Medical a private or public company?

    Genome Medical is a Private company.

  • What is Genome Medical’s current revenue?

    The current revenue for Genome Medical is .

  • How much funding has Genome Medical raised over time?

    Genome Medical has raised $120M.

  • Who are Genome Medical’s investors?

    Amgen Ventures, Edge (Onalaska), GV, iSelect Fund, and Alumni Ventures are 5 of 23 investors who have invested in Genome Medical.

  • Who are Genome Medical’s competitors?

    InformedDNA, InterpretOmics, Blueprint Genetics, My Gene Counsel, and Helix (Laboratory Services (Healthcare)) are some of the 19 competitors of Genome Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process